Plasma plastin-3: A tumor marker in patients with non-small-cell lung cancer treated with nivolumab

Plastin-3 (PLS3) is a circulating tumor cell marker associated with aggressive cancer phenotypes. The present study aimed to investigate the usability of plasma PLS3 concentration in assessing the diagnosis, prognosis and sensitivity to treatment in patients with non-small-cell lung cancer (NSCLC) t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Lett
Asıl Yazarlar: Kuriyama, Kengo, Yokobori, Takehiko, Sohda, Makoto, Nakazawa, Nobuhiro, Yajima, Toshiki, Naruse, Ichiro, Kuwano, Hiroyuki, Shirabe, Ken, Kaira, Kyoichi, Saeki, Hiroshi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2021
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681218/
https://ncbi.nlm.nih.gov/pubmed/33240417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12272
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller